Atrium Innovations Inc, a maker of dietary supplements, said a group of investors, including European private equity firm Permira funds, would acquire the company for about C$1.1 billion ($1 billion), including debt. Atrium shareholders will receive C$24.00 in cash per share, a nearly 23 percent premium to the stock's Thursday close on the Toronto Stock Exchange.
Atrium Innovations Inc. (Atrium) is a Canada-based company engaged in the development, manufacturing, and commercialization of dietary supplements endorsed by health professionals. Shares of ATB fell by 0.1% or $-0.02/share to $19.58. In the past year, the shares have traded as low as $11.17 and as high as $19.76. On average, 46870 shares of ATB.TO exchange hands on a given day and today's volume is recorded at 25736.
Source
